





Microorganisms 2021, 9, x. https://doi.org/10.3390/xxxxx www.mdpi.com/journal/microorganisms 
Article 
A Novel Biofilm Model System to Visualise Conjugal Transfer 
of Vancomycin Resistance by Environmental Enterococci 
Michael Conwell, James S. G. Dooley and Patrick J. Naughton * 
Nutrition Innovation Centre for Food and Health [NICHE], School of Biomedical Science, Ulster University, 
Cromore Road, Coleraine Co., Londonderry, BT52 1SA, UK; conwell-M1@ulster.ac.uk (M.C.); jsg.dooley@ul-
ster.ac.uk (J.S.G.D.) 
* Correspondence: pj.naughton@ulster.ac.uk 
Abstract: Enterococci and biofilm-associated infections are a growing problem worldwide, given 
the rise in antibiotic resistance in environmental and clinical settings. The increasing incidence of 
antibiotic resistance and its propagation potential within enterococcal biofilm is a concern. This re-
quires a deeper understanding of how enterococcal biofilm develops, and how antibiotic resistance 
transfer takes place in these biofilms. Enterococcal biofilm assays, incorporating the study of antibi-
otic resistance transfer, require a system which can accommodate non-destructive, real-time exper-
imentation. We adapted a Gene Frame® combined with fluorescence microscopy as a novel non-
destructive platform to study the conjugal transfer of vancomycin resistance in an established en-
terococcal biofilm.A multi-purpose fluorescent in situ hybridisation (FISH) probe, in a novel appli-
cation, allowed the identification of low copy number mobile elements in the biofilm. Furthermore, 
a Hoechst stain and ENU 1470 FISH probe identified Enterococcus faecium transconjugants by ex-
cluding Enterococcus faecalis MF06036 donors. Biofilm created with a rifampicin resistant E. faecalis 
(MW01105Rif) recipient had a transfer efficiency of 2.01 × 10−3; double that of the biofilm primarily 
created by the donor (E. faecalis MF06036). Conjugation in the mixed enterococcal biofilm was triple 
the efficiency of donor biofilm. Double antibiotic treatment plus lysozyme combined with live/dead 
imaging provided fluorescent micrographs identifying de novo enterococcal vancomycin resistant 
transconjugants inside the biofilm. This is a model system for the further study of antibiotic re-
sistance transfer events in enterococci. Biofilms promote the survival of enterococci and reduce the 
effectiveness of drug treatment in clinical settings, hence giving enterococci an advantage. Entero-
cocci growing in biofilms exchange traits by means of horizontal gene transfer, but currently avail-
able models make study difficult. This work goes some way to providing a non-destructive, molec-
ular imaging-based model system for the detection of antibiotic resistance gene transfer in entero-
cocci. 
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1. Introduction 
Biofilm-associated infections are a major cause of morbidity and mortality world-
wide [1]. Treatment is complicated by difficulties with antibiotic delivery and recent evi-
dence suggests that biofilm is a likely hotspot for antibiotic resistance transfer, thereby 
facilitating the development of multi-resistant strains [2]. Enterococci, including Entero-
coccus faecalis and Enterococcus faecium, are, after Staphylococcus aureus, the second most 
frequently isolated Gram-positive bacteria with associated antibiotic resistance [3] and, as 
with S. aureus, it is widely accepted that new ways to study and combat antibiotic re-
sistance need to be developed [4]. Enterococci were previously associated mainly with 
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urinary tract infections, but there is now a recognition of their importance in other infec-
tions [5,6], complicated by their association with organ transplants [7]. However, despite 
the number of models and approaches suggested [8,9], we have yet to develop reproduc-
ible means of identifying and visualising antibiotic resistance gene transfer in enterococci. 
Current models and the analysis of biofilms therein do not preserve the delicate structures 
of biofilm sufficiently for the study of horizontal gene transfer in biofilm [10]. 
Biofilm formation involves arrays of bacterial cells and extracellular polymeric sub-
stances adhered to a solid substrate [11,12]. Development of the biofilm both through cel-
lular division and the introduction of new individuals occurs until a multispecies com-
munity has been established [13]. Biofilm models of development and biological function 
were initially based on Pseudomonas aeruginosa and Pseudomonas fluorescens research [14]. 
In terms of enterococci, models of biofilm development are not yet fully described, and an 
understanding of their biological function has only recently begun to emerge [8]. Entero-
coccal biofilm is an environment conducive for the exchange of information. This is facil-
itated by intercellular signalling pathways such as the fsr [15], pheromone-dependent and 
horizontal gene transfer (HGT) systems [16] and enterococcal surface proteins [17]. It may 
be that horizontal gene transfer within a biofilm is inefficient as compared to laboratory 
methodologies [18]. Indeed, Breuer et al. [19] demonstrated the likely disparate process 
and efficiency of enterococcal conjugation in the enteric environment as compared to their 
previous in vitro studies. There is high cell density and close contact amongst bacterial 
cells within a biofilm matrix. This, together with increased genetic competence and the 
accumulation of mobile genetic elements in the environment, creates a potential hotspot 
for the acquisition and spread of antibiotic resistance genes [20,21]. 
One of the major issues experienced in the identification of antibiotic resistance gene 
transfer in biofilm is the structural integrity of the biofilm itself. Our previous work has 
identified the importance of the pheromone-linked transfer of vancomycin resistance in 
enterococci [22] and in freshwater sponges [23]. Here, we have investigated how vanco-
mycin resistance transfer can be identified and visualised in biofilm in situ. Many of the 
current techniques used to examine biofilm are destructive. They fail to protect the deli-
cate underlying structures of developing biofilm and are unable to detect gene transfer. 
We have used a Gene Frame® apparatus (GFA) in a novel application to provide support 
to a developing biofilm, allowing the development and maintenance of a delicate biofilm 
structure. We have combined this platform with the use of non-destructive fluorescence 
microscopy along with molecular techniques to detect vancomycin resistance gene trans-
fer in enterococcal biofilm. 
2. Materials and Methods 
2.1. Bacterial Strains and Fluorescent In Situ Hybridisation (FISH) Probes 
All Enterococcus isolates (Table 1) were retrieved from frozen stocks (−80 °C) and were 
maintained as previously described [22]. All probes were acquired through the Ther-
moFisher (Lutterworth, UK) custom DNA primers and, where specifically stated, Inte-
grated DNA Technologies primer creation tools. The vanA probes were conjugated with 
Fluorescein (FITC). The 16S E. faecalis and 23S E. faecium rRNA FISH probes first used by 
Wellinghausen et al. [24] were used here to identify previously characterised E. faecalis 
and E. faecium (Table 1) [22]. These probes were 5′ conjugated with Alexa fluor 594 and 
used to confirm all enterococci in biofilms. The multiplexing PCR technique has previ-
ously been described for simultaneous enterococcal vancomycin resistance gene detection 
[25,26]. Using the same principles to select a suitable primer set for multiple PCR, we se-
lected two probe sequence targets on the enterocococcal vanA (NCBI Reference Se-
quenceNC_014475.1) cluster which would be compatible in a multiplexing reaction. We 
used primer BLAST against all deposited vanA gene sequences in the NCBI database to 
ensure specificity. These probes were crosschecked for stability using the PCR primer sta-
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tistics tool in the sequence manipulation suite [27]. Analogous to the detection of low con-
tent number targets first highlighted by Pernthaler et al. [28], we used two oligonucleotide 
probes simultaneously. These were utilised in a hybridisation reaction targeted to the 
same gene to produce a compounding increase in the fluorescence signal. All reactions 
were controlled using E. faecalis ATCC 29212 with S. aureus ATTC 43300 employed as a 
non-specific control for Enterococcus probes. All chemicals and antibiotics used were 
sourced from Sigma-Aldrich (Dorset, UK), unless otherwise stated. 
Table 1. Bacterial strain information. 
Isolate Species Resistance Biofilm Production Conjugation Role Reference 
MF06036 E. faecalis Van, Ery, Tet Moderate Donor [22] 
MW01105Rif E. faecalis Rif Moderate Recipient [22] 
ST01109Rif E. faecium Rif Moderate Recipient [22] 
MF04010 E. faecalis Tet, Gen Moderate Donor [29] 
Van—vancomycin, Ery—erythromycin, Tet—tetracycline, Rif—rifampicin, Gen—gentamycin. 
2.2. Culture Conditions for Growth of Enterococcal Biofilm 
All enterococcal biofilms were grown in Tryptone Soya Broth (TSB), (CMO129, Ox-
oid, UK), (1% glucose) for 24–48 h statically at 37 °C. Briefly, enterococci were grown in 
TSB to approximately 2.5 × 109 CFU/mL. Cells were harvested, resuspended and diluted 
1:200 in TSB (1% glucose) and inoculated onto all surface conditions (below). For conju-
gation reactions in the GFA, cellular inoculations were approximately 2.5 × 106 CFU/mL. 
Prior to inoculation all surfaces were coated with gelatin (Sigma-Aldrich, Dorset, UK). 
Gelatin was prepared as a 2% (w/v) stock in tissue grade H2O (ThermoFisher, Lutter-
worth, UK), autoclaved and coated on substrate (10 µL/cm2) and dried in a tissue culture 
hood for 2 h. For coverslip biofilms, 16-well polystyrene microplates (ThermoFisher, Lut-
terworth, UK) with a 10 mm circular glass coverslip (ThermoFisher, Lutterworth, UK) 
were coated in gelatin and placed flat along the bottom of each well and used to grow 
enterococci. For microplate biofilms, enterococci were grown in 48-well polystyrene mi-
croplates (ThermoFisher, Lutterworth, UK) coated with gelatin. For GFA biofilms, dou-
ble-sided adhesive Gene Frames® were attached to glass microscope slides (ThermoFisher, 
Lutterworth, UK) coated with gelatin. These were UVC sterilised for 45 min according to 
manufacturers’ instructions (CL-100 UV Crosslink, UVP, UK). Enterococcal biofilm inoc-
ula were prepared and placed within the Gene Frame well inside a tissue culture hood 
and sealed using the top side adhesive and supplied coverslips. 
2.3. Characterisation of the GFA Grown Biofilm 
Concanavalin A (Con-A) Texas red conjugate (Invitrogen, Renfrew, UK) was used to 
stain the enterococcal biofilm. A stock solution of 1 mg/mL in 0.1 M sodium bicarbonate 
(pH 8.3) (with 2 mM sodium azide added before storage) was diluted to working concen-
trations of 25–50 µg/mL with incubation times of 30–60 min at room temperature (RT). 
2.4. Quantification of Cell Biomass 
Quantification was carried out on raw image files for cellular staining (Hoechst) and 
extracellular polymeric substance( EPS), (Con-A) converting staining to 8 bit images using 
ImageJ (NIH). Data was analysed using GraphPad Prism (Version 6.0). 
2.5. Fluorescent Imaging of Enterococci in Biofilm 
Biofilm staining was performed in situ using final staining volumes of 100 µL. Bio-
film was washed three times with 1000 µL of phosphate buffered saline (PBS). Hoechst 
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33342 (Sigma-Aldrich, Dorset, UK) DNA stain stocks of 10 µg/mL in DMSO were opti-
mised for detecting enterococci at a working concentration (diluted in PBS) 2.5 µg/mL for 
biofilm. All Hoechst incubation times were 15 min at RT. 
The live/dead BacLight bacterial viability kit L7012 which included the SYTO9 stain 
(ThermoFisher, Lutterworth, UK) was used for live/dead staining of enterococci as per 
manufacturer’s instructions. Stains were applied at a concentration of 0.003% v/v and in-
cubated at RT for 20 min for enterococcal biofilms. Stains were washed with PBS (×3, dried 
and mounted using mounting medium (Vectashield) for fluorescence microscopy. Mi-
croscopy was carried out with a 100x objective on a Nikon eclipse E400 with a Nikon DS-
fi1c using a G2-A and UV filter set. Images were captured with NIS-elements and ImageJ 
(NIH). 
2.6. Detection of Conjugation in Biofilm using the Gene Frame® 
Gene Frames® (ThermoFisher) are typically used for in situ hybridisation and PCR 
reactions to detect genetic targets in histological tissue sections [30,31]. Gene Frames are 
superior to hydrophobic pens and parafilm® as they are more robust for multistep exper-
imental approaches. They are also less damaging to materials under study and prevent 
the evaporation of testing solutions [32]. The Gene Frame is used in the current study and 
developed as the Gene Frame Apparatus (GFA), providing a model system to study con-
jugation in biofilm. It provides a novel approach to develop a scaffold for analysing bio-
film development coupled with gene detection in a non-destructive manner. Biofilm de-
velopment in the GFA was initially examined using phase contrast microscopy (see Figure 
1), [22]. A biofilm-forming vanA donor strain (MF06036) was added (30 µL of TSB 1% 
glucose culture at 2.5 × 106 CFU/mL) to a Gene Frame on a gelatin-coated slide (10 µg/cm2), 
sealed and incubated at 37 °C for 24 h. The plastic seal was aseptically removed, and the 
biofilm washed in sterile PBS to remove planktonic cells. The recipient strain (MW01105Rif) 
was added (30 µL of TSB 1% glucose culture at 2.5 × 106 CFU/mL) to the pre-established 
biofilm, sealed and incubated for a further 24 h at 37 °C. The Gene Frame was removed, 
and biofilm was washed with PBS. The biofilm was then scraped off and homogenised in 
dimethyl sulfoxide (DMSO) (30 µL) to prevent aggregation [18]. The homogenate was 
added to double selection plates (vancomycin 10 µg/mL and rifampicin 100 µg/mL) and 
incubated for 24 h at 37 °C. Resultant transconjugant colonies were enumerated as de-
scribed by Conwell et al. [22]. Transfer efficiencies were calculated as number of transcon-
jugants per donor. 




Figure 1. Comparison of a biofilm assay on a coverslip with the Gene Frame® apparatus (GFA) 
applied to E. faecalis MF04010. All biofilms were grown for 24 h at 37 °C under static growth condi-
tions. (a,b) 40x micrographs of the coverslip method (a) and the Gene Frame (b). (c,d) 40x phase 
contrast micrographs (c), highlighting free-floating, detached biofilm masses that occurred when 
processed for microscopic visualisation (d). The Gene Frame method generated minimal biofilm 
surface detachment. (e,f) 100x micrographs imaged with fluorescence and Hoechst DNA staining 
(blue) (panels e,f). The coverslip method (e) dislodged large quantities of cells into the planktonic 
phase through processing. The gene frame (f) minimised this phenomenon. Scale bar for images 
(a–d) represents 50 microns. Scale bar for (e,f) represents ten microns. 
Variations on the conjugation of enterococci within biofilm were performed as fol-
lows. A “donor” biofilm was one whereby the donor (MF06036) was used to initiate bio-
film formation and the recipient (MW01105Rif) was added to the pre-established biofilm. 
A “recipient” biofilm was one whereby the recipient (MW01105Rif) was used to initiate 
Microorganisms 2021, 9, x FOR PEER REVIEW 6 of 17 
 
 
biofilm and the donor (MF06036) was added to the pre-established biofilm. A “mixed” 
biofilm was one whereby both partners were added simultaneously to initiate biofilm for-
mation. 
2.7. Fluorescent In Situ Hybridisation (FISH) Detection of Enterococcal Cells and vanA 
Antibiotic Resistance Gene in Biofilm 
Hybridisation procedures to detect enterococcal cells were adapted from Waar et al. 
[33]. Enterococcal biofilms were first grown in the GFA for 48 h at 37 °C under static 
growth conditions. Coverslips were carefully removed, leaving the Gene Frame intact sur-
rounding the biofilm. Biofilms were then washed with PBS and fixed in 97% ethanol for 
five minutes. The GFA incorporating the fixed biofilms were treated (in a humidified hy-
bridisation chamber) with lysozyme (1 mg/mL) for 30 min at 37 °C. After 30 min, the bio-
film was probed (Table 2) with either ENF 191, or ENU 1470 (10 ng/µL) in 10% formamide 
for 2–24 h at 50 °C. Cells were washed (3 × 5 min) in wash solution (0.9 M NaCl, 20 Mm 
Tris-HCl (pH 7.5) at RT and air dried. The GFA was removed from the humidified cham-
ber and the slides were mounted with Vectashield® mounting medium for fluorescence 
microscopy. Slides were imaged with a 100x objective on a Nikon eclipse E400 with a Ni-
kon DS-fi1c using a G2-A and UV filter set. Images were captured with NIS-elements and 
ImageJ (NIH). 
Table 2. Probes used for fluorescent in situ hybridisation (FISH). 
Target Probe Sequence 5′ to 3′ Reference 
Enterococcus 
vanA vanA 1 GCAAGTCAGGTGAAGATGGA This study 
 vanA 2 AGGAGCATGACGTATCGGTA This study 
E. faecalis 16S 
rRNA ENF 191 
GAAAGCGCCTTTCAC-
TCTTATGC [24] 






For fluorescent in situ hybridisation of vancomycin-resistant enterococci containing 
the vanA gene, biofilms were prepared as above with the following modification. The van-
comycin-resistant E. faecalis MF06036 was grown for 48 h using biofilm inoculum and 
growth media that contained 10 µg/mL vancomycin. Pre-treatment with vancomycin was 
essential for a strong signal. The standard FISH assay described by Warr et al. [33] was 
modified to target two binding sites across the vanA vancomycin resistance gene 
(NC_014475.1). The two probes selected that bound vanA were designed to be the same 
length and have the same annealing temperature. This design approach eliminated mul-
tiple annealing steps within the protocol. Fixed biofilms were incubated with the two dis-
tinct fluorescein-labelled FISH probes specific to vanA (Table 2) for 2–24 h at 50 °C in 10% 
formamide at 50ng/µL. An Alexa fluor 594 probe targeted to E. faecalis 16S rRNA (ENF 
191) was used as a control. Slides were imaged as described above. 
2.8. Visualisation of Enterococcal Transconjugants in a Conjugal Biofilm 
Enterococcal conjugations in biofilm using the Gene Frame® were carried out as 
above between MF01105rif and MF06036. Post-conjugation, antibiotic selection (10 µg/mL 
vancomycin and 100 µg/mL rifampicin, or tetracycline 30 µg/mL) was applied directly to 
the conjugal biofilms incubated at 37 °C for 24 h. Lysozyme (2 mg/mL) was then added 
for an additional 24 h at 37 °C. Biofilms were then subjected to live/dead and FISH staining 
protocols and imaged with a 100x objective on a Nikon eclipse E400 with a Nikon DS-fi1c 
using a G2-A and UV filter set. Images were captured with NIS-elements and ImageJ 
(NIH). 
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2.9. Statistical Analysis 
Assays performed on the GFA were performed five times with six biological repeats. 
Microscopy-based statistics came from 10 regions of interest with three independent re-
peats. Averages were taken and when appropriate standard error of the mean was dis-
played. Significance was computed using GraphPad Prism 6 t-test function, one way and 
two-way analysis of variance. 
3. Results and Discussion 
3.1. Growth of Biofilm in GFA 
The use of the GFA permitted the growth and visualisation of enterococcal biofilm 
by employing as little as possible physical processing and manipulations to samples (Fig-
ure 1). This was found to be superior to the coverslip and polystyrene microplate method 
. The coverslip method required manipulation of the slips with forceps, with inversion 
and mounting to a slide for microscopic visualisation. These processes could be omitted 
when using the GFA. The microplate method required significant micropipette aspirating 
when staining, whereas the GFA could be stained with decanting and tissue aspiration. 
From Figure 1, the coverslip method (a) was employed against the Gene Frame (b). The 
coverslip method retained a small quantity of the biofilm post-processing, evident by the 
lack of extracellular content within the biofilm boundary (dashed line). The Gene Frame 
method produced biofilm with a high density that retained the majority of extracellular 
content within the biofilm boundary. 
Figure 1c highlights free-floating, detached biofilm masses that occur when pro-
cessed for microscopic visualisation from the coverslip method; whereas in Figure 1d the 
Gene Frame method generated minimal biofilm surface detachment when processed for 
microscopic visualisation. There were zero instances of free-floating biofilm mass in the 
Gene Frame experiments. Cell retention differences between polystyrene microplate (e) 
and Gene Frame (f) methods were apparent. The microplate method rends large quanti-
ties of cells into the planktonic phase; whereas the Gene Frame sufficiently minimised this 
phenomenon, but not without total elimination. 
3.2. Characterisation of Biofilm using Con-A Staining of EPS 
The Con-A staining of the enterococcal biofilm matrix is illustrated in Figures 2 and 
3. Figure 2 shows clustered staining under low magnification as well as punctuated stain-
ing of inclusions, shown under higher magnification in Figure 3. Early set down and for-
mation of MF04010 biofilm was observed using the GFA, as seen in Figure 3a–d. Figure 
3a was imaged 2 h after cells were added to the GFA. The attachment sites and production 
of EPS can be observed with the Con-A staining (red). At 6 h, Figure 3b demonstrates large 
quantities of extracellular material stained with Con-A. At 12 h, Figure 3c shows greater 
proportions of EPS (red) compared to the cellular biomass (blue overlapping red) alone. 
Figure 2e shows significant quantification of EPS at 12 h (p = 0.0001) and 24 h (p = 0.0083). 




Figure 2. Con-A and SYTO9 effectively stains the EPS and cellular content of enterococcal biofilm in the Gene Frame 
biofilm apparatus (GFA). (a) 10x composite micrograph of 24-h biofilm produced by MF04010 using a dark field and the 
G2-A filter to capture the red fluorescence staining of Con-A bound to the EPS. (b) 100× fluorescent micrograph of MF06036 
24-h biofilm stained for cellular content with SYTO9 (green) and EPS with Con-A (red). 
 
Figure 3. The GFA can be used to visualise and quantitate the biofilm development of MF04010. Biofilms were stained 
with Con-A (red) and Hoechst (blue) and imaged with florescence microscopy. (a) 100x micrograph of 2-h biofilm growth. 
(b) 100× micrograph of 6-h biofilm growth. (c) 100× micrograph of a 12-h biofilm growth. (d) 40× micrograph of a 24-h 
biofilm growth. Scale bar for 100× micrographs (a–c) represents 10 microns. (e) Graph of quantification of cell biomass 
staining versus EPS staining of MF04010. The Hoechst and Con-A micrographs from the biofilm growth of MF04010 were 
imported into ImageJ. Micrographs were converted to 8-bit images and the % grey pixel areas were computed as per the 
ImageJ analyse-measure function. At the 12-h time-point the P value between cell biomass and EPS was 0.0001. At the 24-
h time-point the p value between cell biomass and EPS was 0.0083. 
3.3. Detection of vanA in Biofilm Using Multi-Probe FISH 
FISH detection of plasmid-bound vanA is shown in Figure 4 by the application of the 
vanA probes . Figure 4 a, b examines the vanA negative staining control. Figure 4a shows 
phase contrast imaging of MF04010 biofilm grown (48 h) in TSB with 1% glucose under 
static conditions. Figure 4b shows green fluorescence imaging of the same region. Figure 
4c,d show the addition of (10 µg/mL) vancomycin for a further 24 h, to the vanA positive 
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MF06036 in a 24-h pre-established biofilm grown with TSB (1% glucose) at 37 °C. Figure 
4c shows phase contrast imaging of MF06036 vancomycin exposed biofilm along with 
green fluorescence imaging of the same region, shown in Figure 4d. Figure 4e,f show a 
100× micrograph of the addition of (10 µg/mL) vancomycin to the biofilm formation media 
TSB (1% glucose) during the formation of isolate MF06036′s biofilm (24 h). Media was 
replaced at the 24-h time point with (10 µg/mL) vancomycin TSB (1% glucose) for an ad-
ditional 24 h, and Figure 4e shows the phase contrast imaging of MF06036 vancomycin 
exposed biofilm. Figure 4f shows green fluorescent imaging of the same region. 
 
Figure 4. Multi-probe FISH successfully detected plasmid bound vanA fluorescein (green) re-
sistance genes in enterococcal biofilm. (a,b) 100x micrograph overlays of a negative biological con-
trol using MF04010 and fluorescein probes targeted to the vanA vancomycin resistance gene. (a) 
Phase contrast imaging to highlight MF04010, 48-h biofilm cells grown with TSB (1% glucose) at 37 
°C incubated statically. Media was replaced at the 24-h time point. (b) Green fluorescent imaging 
of the same region. (c,d) 100× micrograph overlays of the addition of sub inhibitory (10 µg/mL) 
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vancomycin for 34 h, to the vanA positive MF06036 in a 24-h pre-established biofilm grown with 
TSB (1% glucose) at 37 °C. (c) Phase contrast imaging MF06036 vancomycin exposed biofilm. (d) 
Green fluorescent imaging of the same region. (e,f) 100× micrograph overlays of the addition of 
sub inhibitory (10 µg/mL) vancomycin to the biofilm formation media TSB (1% glucose) during 
the formation of isolate MF06036′s biofilm (24 h). Media was replaced at the 24-h time point with 
vancomycin TSB (1% glucose) for an additional 24 h. (e) Phase contrast imaging MF06036 vanco-
mycin exposed biofilm. (f) Green fluorescent imaging of the same region. Scale bar represents ten 
microns. Arrowhead—fluorescence artefact, arrow—cell positive for vanA staining. 
3.4. Detection of vanA Transconjugants in Biofilm 
A biofilm conjugation reaction was established with the recipient (either MW01105Rif 
(Figure 5) or ST01109rif (Figure 6) and donor MF06036. Isolates MW01105rif and MF06036 
were used previously to demonstrate the transfer of vancomycin resistance by conjuga-
tion [22]. Figure 5 quantifies the successful isolation of the vanA transconjugants from 
conjugation reactions between the recipient and donor in three different biofilm reactions, 
as described in the methods. Biofilm created with MW01105Rif had a transfer efficiency of 
2.01 × 10−3 (150.75 CFU); double that of the biofilm primarily created by the donor (biofilm 
created with MF06036) at 1.01 × 10−3 (75.75 CFU). Conjugation in the mixed enterococcal 
biofilm was three times as efficient as the donor biofilm with an efficiency of 3.04 × 10−3 
(228 CFU). Statistically there was no difference between these three types of biofilm con-
jugation tests, excluding a comparison of the donor-only biofilm against the mixed biofilm 
(p value of 0.0048 ** using Welch’s correction). However, a mixed biofilm (without ac-
counting for planktonic enterococci) yielded an improvement in the generation of trans-
conjugants. 
 
Figure 5. Application of double antibiotic selection and lysozyme degradation permitted the suc-
cessful selection of transconjugants inside 24-h biofilms. (a) 100× micrograph of a biofilm made 
with MW01105Rif. (b) 100× micrograph of a biofilm made with MF06036. (c) 100× micrograph of a 
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conjugation reaction with MW01105Rif and MF06036 inside biofilm. Subfigures (a–c) were visual-
ised with live/dead BacLight staining (green/red) after treatment with double selection (10 µg/mL 
vancomycin, 100 µg/mL rifampicin) to inhibit/kill cells. The biofilm was then treated with lyso-
zyme (2 mg/mL) for a further 24 h to eradicate the compromised cells. (d) A graph showing the 
total cell count of the three biofilms visualised in (a–c). Error bars represent the standard error of 
the mean of each cell count group for MW01105Rif, MF06036 and MW01105Rif + MF06036. Experi-
ments were carried out with six biological repeats and five independent repeats. Statistics gener-
ated from each repeat used 10 regions of interest. Scale bar represents ten microns. Significance 
**** p = 0.0001, significance ** p = 0.002. 
 
Figure 6. Application of FISH on a mixed-species enterococcal conjugation reaction inside biofilm 
successfully identified transconjugants. (a,b) are fluorescent micrographs of a conjugation reaction 
between E. faecalis MF06036 and E. faecium ST01109Rif inside biofilm. Biofilm was created, and en-
terococci allowed to conjugate for 24 h. Post-conjugation, biofilm was treated with tetracycline (30 
µg/mL) for 24 h, and then treated with lysozyme (2 mg/mL) for an additional 24 h. (a) 100× fluo-
rescent micrograph showing Hoechst staining of tetracycline and lysozyme treated biofilm post-
enterococcal conjugation. (b) FISH staining of same region as (a) with probes specific for E. faecium 
only. White dashed ovoid depicts region of interest with total cell count stained blue (a) and 
stained red (b) with E. faecium cells only. 
The GFA has the disadvantage that visualisation of transconjugants can be difficult 
in biofilms of high cell density. Therefore, we set out to eliminate the parent strains in the 
biofilm so that visualisation of the transconjugants would be possible. Figure 5a–c clearly 
demonstrates microscopically the synergistic killing of MW01105Rif (a), MF06036 (b) and 
the successful conjugation of MW01105Rif and MF06036 (c) highlighted with live SYTO9 
green imaging. Figure 5d is a total cell count of the three biofilms visualised in (a–c). As 
this was a biofilm conjugation experiment with MW01105Rif, MF06036 and freshly created 
transconjugants, these increased numbers of dead and structurally compromised cells 
were expected. 
3.5. Visualising HGT between Species 
Figure 6a,bare fluorescent micrographs of a mixed-species biofilm conjugation reac-
tion between E. faecalis MF06036 and E. faecium ST01109Rif. Due to the selection conditions, 
the only remaining enterococci in this biofilm were MF06036 (all blue stained cells that do 
not co-localise with red staining) and the resultant transconjugants from the conjugation 
reaction, which was stained with the FISH probe. Washing steps during the methodology 
ensured planktonic cells were washed away and binding controls ensured that non-spe-
cific signals did not interfere with data collection. The Hoechst photo-conversion did not 
enter the B2-A blue filter on the fluorescent microscope. This assay provided visual evi-
dence of enterococcal conjugation within biofilm, by way of specifically labelling surviv-
ing recipients from donors within undisturbed biofilm. This approach permitted the vis-
ualisation of transconjugants ensured to be only created from within biofilm. 
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3.6. Application of Gene Frame Apparatus Model to Biofilm Studies 
In our hands, the GFA model has been shown to have several advantages over tradi-
tional visualisation methods [34], principally minimal surface detachment and increased 
cellular density. The GFA allowed the imaging of the early stages of biofilm formation 
(Figures 2 and 3) using a standard fluorescence microscope in a non-destructive manner. 
Figure 2a depicts the diffuse nature of MF04010 biofilm, an observation not apparent in 
every isolate, for example MF06036 (Figure 2b). Biofilm from MF06036 formed with an 
apparent high cellular density of individual coccoid cells (Figure 2b). This morphology is 
atypical of MF06036 as it normally appears in diplococcus form in planktonic phase [22]. 
Biofilm formation capability is a function of cell attachment to a solid substrate, adhesion 
and growth [8,35–37]. There are also distinctive biofilm formation variations based on 
static or laminar flow growth conditions [38]. Most assays manipulate some of these char-
acteristics to optimise biofilm biomass and produce an easily measurable signal. How-
ever, this approach may have a negative impact on the functionality of bacteria in the 
biofilm state, such as a model of in vivo persistent antibiotic-resistant infection [39]. There 
is a growing consensus that bacteria modulate their biofilm to adapt to changing condi-
tions of stress, rather than simply producing biofilm in large quantities irrespective of ex-
ternal conditions [38,40,41]. 
The novel application of the GFA here to biofilm studies allowed the visualisation of 
what has been identified as fragile enterococcal biofilm [42]. The majority of current tech-
niques, including the polystyrene microplate assay [43] and submerged coverslip biofilm 
formation assay [44], can be destructive to the delicate structures of biofilm, thus making 
in-depth analysis of interactions including visualisation of antibiotic resistance genes ex-
tremely difficult [29]. In our hands, the GFA has been shown to have several advantages 
over traditional visualisation methods [45], principally minimal surface detachment and 
increased cellular density (Figure 1). This unique characteristic of the GFA allowed un-
processed, undisturbed imaging of 24–48-h biofilm (Figure 1) using a standard fluores-
cence microscope in a non-destructive manner. 
3.7. Deployment of Con-A to Identify EPS in Biofilm 
The lectin, Con-A, binds to α-mannopyranosyl and α-glucopyranosyl residues of car-
bohydrates [46]. Enterococcal cell wall components feature lipoteichoic acids with kojibi-
ose containing an α-D glucopyranosyl residue [47]. Con-A binds to polysaccharide resi-
dues and so, attached to a suitable fluorochrome, it can be used as a selective stain to 
examine biofilm formation and EPS production [48,49]. Previously, Con-A has been used 
to identify various types of cells, including those found in archaeal and bacterial biofilm 
[50]. Hence, the capacity of Con-A to bind to a range of capsular/cell-associated structures 
suggests similarities in EPS composition. It has been used previously in our laboratory to 
show reduced EPS production in a Burkholderia thailandensis transposon mutant [51]. Flu-
orescently labelled Con-A was also shown to stain the α-linked mannose and α-linked 
D-glucose components of enterococcal EPS [52]. In the current study, the Con-A Alexa 
Texas red staining of EPS eclipses DNA staining due to continual EPS formation in the 
biofilm (Figure 3). In comparison with the diplococcus form, the lack of staining where 
enterococci form chains, suggests lower EPS/biofilm formation. 
3.8. FISH Visualisation of vanA Transconjugants 
The GFA allowed for the development of a multi-probe FISH protocol for easy anal-
ysis of enterococci in biofilms, and for the first time, allowed the visualisation of vanA-
containing cells. In the current study, probes from a commercial supplier were all the same 
length and had the same annealing temperatures much like a multiplex PCR [53]. FISH 
assays have been previously used to monitor the presence of enterococci in faecal matter 
and activated sludge from wastewater treatment plants using genomic identifiers such as 
16S or 23S rRNA [54,55]. In the current study, the novel application of FISH identified low 
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copy number AMR mobile genes without molecular amplification steps. Previous modi-
fications to the FISH protocol have included introducing reporter genes into plasmids and 
replicating the modified plasmid into Enterococcus [18]. The multi-probe oligonucleotide 
FISH developed here, to target a single enterococcal gene in biofilm state, follows Zwir-
glmaier et al. [56] and their multi-fluorophore FISH probe designed to target single genes. 
The current study reduces some of the complexity and cellular internalisation limitations 
imposed by the RING FISH probes [56]. Crucially, selective pressure of vancomycin (10 
µg/mL) during the formation of the MF06036 biofilm, in tandem with the increased vanA 
double probe concentrations (50ng/µL) and incubation, is essential to secure a signal. The 
signal is lost completely when standard probe concentrations and incubation time are 
used with only a single vanA probe. Therefore, the improvements to the protocol high-
lighted here were crucial in the identification of vanA within E. faecalis MF06036 without 
the need for complex amplification steps. This type of FISH reaction has also been used to 
quantitate the physical transcripts involved in the conjugation of the pCF10 plasmid in E. 
faecalis [19]. 
The GFA additionally allowed for a multi-stage vanA conjugation assay to be demon-
strated in enterococci in the biofilm state, whilst eliminating planktonic cells from any 
results. The nature of this protocol (Figure S1) ensured that planktonic conjugation was 
eliminated due to the removal of all non-adherent cells prior to the addition of the conju-
gation partner. 
3.9. In Situ Detection of Transconjugants 
The facilitation of conjugation reactions to occur inside biofilm, then applying both 
the selective pressure of antibiotics (rifampicin and vancomycin) and the action of lyso-
zyme, identified transconjugants situated within enterococcal biofilm for the first time 
(Figure 5). The vanA transconjugants had combined vancomycin, rifampicin and lyso-
zyme MICs four times higher than the donor and eight times higher than the recipient 
(data not shown). This resulted in the selective killing and lysozymic degradation of the 
parent strains, making microscopic visualisation of the surviving transconjugants possi-
ble. An additional experiment was performed, whereby an interspecies conjugation reac-
tion was examined using FISH and double selection (tetracycline and lysozyme), high-
lighting only the transconjugants from E. faecium ST01109Rif (Figure 6 a,b). Any remaining 
E. faecium ST01109Rif recipients were eliminated by the double selection, thus excluding 
any non-specific live/dead staining of the transconjugant. Furthermore, the Hoechst stain 
and the ENU 1470 FISH probe selected for E. faecium transconjugants (excluding E. faecalis 
MF06036 donors). This double antibiotic treatment plus lysozyme combined with 
live/dead imaging provided the first report of fluorescent micrographs identifying de novo 
transconjugants inside biofilm. 
4. Conclusions 
Biofilm studies are assay-dependent, whether it is a measure of biofilm formation 
based on cell counting alone, the ratio of cells to biomass or dry biomass alone [57–61]. 
There is a clear need for a consensus regarding the standardisation of growth conditions 
for enterococci prior to carrying out detailed experimental studies. There is also a need to 
refine the methods available for the detection of resistance genes so they can be applied 
to biofilms/biofilm studies. The multi-probe FISH developed in the current study is a sim-
ple, cheap and novel method for the examination of enterococcal biofilms from environ-
mental isolates containing mobile resistance, e.g., vanA genes, using epifluorescence. 
However, it is well understood that enterococci form biofilm in many environments, e.g., 
river basins, medical devices, animal intestine and circulatory systems [62–65]. These en-
vironments all have, to varying degrees, conditions of laminar and turbulent flow, which 
the GFA cannot adequately replicate in vitro, as it has been designed to facilitate entero-
coccal biofilm processes under static conditions. Indeed, several enterococcal pathologies 
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involve translocation from catheter and intestinal colonisations to bacteraemia and endo-
carditis [36,66]. Antibiotic-resistant enterococcal infection has been implicated from river 
ecosystems with proximity to farming processes and urban wastewater effluent [67–69]. 
Therefore, devices such as the BioFlux flow-through device and drip flow biofilm reactor, 
which are designed to grow biofilms under flow, should be considered against the GFA 
[70,71]. The BioFlux flow-through device is a bespoke microfluidic device that uses etched 
microtiter plates to grow biofilm under fluidic flow, which is highly controllable. How-
ever, it cannot be used to study cellular processes within biofilm in great detail. It cannot 
be opened and have other constituents added or removed in compounding multistage 
experiments, as compared to the GFA which has this capability. The drip flow biofilm 
reactor forms biofilms across a coupon or microscope slide, titled at an angle whereby 
media runs across the substrate, inducing flow. However, the fact that the coupon needs 
to be removed for processing, and biofilms cannot be imaged in situ, significantly reduces 
the overall functionality of this device as compared to the proposed GFA. We suggest that 
in future studies the GFA could be modified to introduce a microfluidic chamber to cap-
ture biofilm modalities from fluidic environments whilst still maintaining the unique ad-
vantages offered with the current setup of this device. The GFA has the potential to allow 
the study of any bacterial biofilm without the limitations applied from the other tech-
niques discussed in this study. Pathogens with similar motility characteristics, such as S. 
aureus, could be visually studied in tandem with the enterococcal vanA transfer mecha-
nism within the GFA as an example. This potential is compounded when regarding 
“poor” biofilm-forming isolates as defined by the traditional techniques, or even isolates 
which may require specific substrate compositions such as gelatin coating [72,73]. Sub-
strate modifications can be applied directly within the GFA, or the frame itself can be 
applied to laboratory-specific substrates for study. Indeed, for enterococci alone there are 
a wide range of techniques and growth media utilised, thus, raising questions into their 
effectiveness and trueness relative to natural biofilm formation [42]. It is a cheap, com-
mercially available apparatus that has the capability of being used for real-time and end 
point biofilm tracking. Since it can be applied to any substrate, this allows for universal 
compatibility with any microscope or imaging system, not just expensive bespoke pack-
ages. 
Improved model systems, including the GFA proposed here, solves the complex 
problem of how to visualise biofilms whilst maintaining important structural characteris-
tics. These systems could give us a better understanding of the drivers of horizontal gene 
transfer in biofilm, and methods to study them could contribute to efforts to reduce the 
spread of resistance genes and prolong the useful life of antibiotics. 
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